GLP-3 (RETA) 30MG

Product Overview

GLP-3 (Retatrutide) is a triple agonist targeting GLP-1, GIP, and glucagon receptors, studied for comprehensive metabolic regulation, energy expenditure, and glycemic control. This 30 mg vial supports extended or higher-throughput research. Supplied as a high-purity lyophilized powder in a sealed, sterile vial for reliable reconstitution and laboratory results.

Key Features

• High Purity: Each batch is rigorously tested for purity and sterility via HPLC and mass spectrometry.
• Lyophilized Powder: Provided in a sealed, sterile vial for easy reconstitution and storage.
• Research-Grade: Formulated specifically for in-vitro and pre-clinical studies.
• COA Included: A Certificate of Analysis is available for every batch.

Research Applications

• Triple-agonist (GLP-1/GIP/glucagon) signaling studies
• Weight-management and fat-oxidation research
• Glycemic control and insulin-sensitivity models
• Obesity and metabolic-disorder investigation

Product Specifications

• Form: Lyophilized powder in a sterile vial
• Available Size: 30MG
• CAS Number: 2381089-83-2
• Storage: Store at -20°C, protected from light and moisture

Disclaimer

This product is sold strictly for scientific research purposes only. It is not intended for human or animal consumption or for the diagnosis, treatment, cure, or prevention of any disease. Handle only by qualified professionals in an appropriate laboratory setting.